-
Targeted gene-altering therapy reduced LDL-cholesterol levels by 50 per cent in patients with severely elevated cholesterol levels.
Medical Mythbusting Commentary for September 2, 2026 Source:With the snip of a gene, scientists hope to erase high cholesterol for life Reference:Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
-
Phase 1 targeted gene editing study demonstrates safety and reduction in LDL cholesterol levels through specific protein pathway
Medical Mythbusting Commentary for August 17, 2026 Source:‘An extremely exciting milestone!’: landmark treatment slashes cholesterol by 62% with a single dose Reference:In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
-
New way to lower high cholesterol by stopping its production demonstrated in mice. It is also designed for a subset of people with a genetically inherited condition that causes significant elevated levels.
Medical Mythbusting Commentary for April 17, 2026 Source:Scientists Discover Game-Changing New Way To Treat High Cholesterol Reference: A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B